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Abstract
Insulin signaling to the brain is important not only for metabolic homeostasis but also for higher brain functions such as
cognition. GABA (c-aminobutyric acid) decreases neuronal excitability by activating GABAA channels that generate phasic
and tonic currents. The level of tonic inhibition in neurons varies. In the hippocampus, interneurons and dentate gyrus
granule cells normally have significant tonic currents under basal conditions in contrast to the CA1 pyramidal neurons
where it is minimal. Here we show in acute rat hippocamal slices that insulin (1 nM) ‘‘turns on’’ new extrasynaptic GABAA
channels in CA1 pyramidal neurons resulting in decreased frequency of action potential firing. The channels are activated by
more than million times lower GABA concentrations than synaptic channels, generate tonic currents and show outward
rectification. The single-channel current amplitude is related to the GABA concentration resulting in a single-channel GABA
affinity (EC50) in intact CA1 neurons of 17 pM with the maximal current amplitude reached with 1 nM GABA. They are
inhibited by GABAA antagonists but have novel pharmacology as the benzodiazepine flumazenil and zolpidem are inverse
agonists. The results show that tonic rather than synaptic conductances regulate basal neuronal excitability when significant
tonic conductance is expressed and demonstrate an unexpected hormonal control of the inhibitory channel subtypes and
excitability of hippocampal neurons. The insulin-induced new channels provide a specific target for rescuing cognition in
health and disease.
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Introduction
The insulin receptor is prominently expressed in the hippo-
campus suggesting that insulin regulates hippocampal function
and thereby possibly modulates cognition [1]. Impaired insulin
signaling increases risk of Alzheimer disease [2], cognitive
disabilities in diabetes mellitus [3] and decreases cerebrocortical
beta activity in overweight humans [4] whereas intranasal
administration of insulin improves hippocampal-dependent mem-
ory function [5]. Nevertheless, the mechanism underlying the
insulin effects on hippocampal function is not understood.
GABA, the main inhibitory neurotransmitter in the CNS binds
to synaptic and extrasynaptic GABAA channels that mediate
phasic and tonic inhibition, respectively. The level of tonic
inhibition in neurons varies [6,7,8,9] and is dependent on the
extracellular GABA concentration plus the GABA affinity of the
channels in the neuronal plasma membrane. During exposure to
novel environment or stress extracellular GABA concentrations
may change [10] implying that GABA-activated tonic conduc-
tances are valuable under these circumstances. Accordingly, tonic
inhibition in the hippocampus appears to modulate cognitive
functions [11,12,13,14,15]. But, what determines subtypes and
subcellular location of GABAA channels and thereby the relative
contribution of synaptic and extrasynaptic currents to neuronal
function is still somewhat elusive.
Since the early 80’s it has been known that insulin inhibits
spontaneous firing of rat hippocampal pyramidal neurons [16] and
in the 90’s it was shown that insulin increases the number of
synaptic GABAA channels [17]. Whether insulin also affects the
extrasynaptic GABAA channels-mediated tonic inhibition in the
hippocampus has not been examined. Here we show that the
major effect of insulin on the hippocampal CA1 pyramidal
neuronal excitability is achieved by increasing the GABA-
mediated tonic inhibitory conductance.
Results
Insulin induces GABAA-mediated tonic current in
hippocampal CA1 neurons
The whole-cell currents were recorded from rat hippocampal
CA1 pyramidal neurons. After applying SR-95531 (20–200 mM), a
GABAA channel antagonist, to control slices bathed in artificial
cerebrospinal fluid (ACSF slices), the spontaneous inhibitory
postsynaptic currents (sIPSCs) were blocked but the holding
current did not or only shifted marginally indicating no or minor
tonic currents activated in the neurons (Fig. 1Aa) and is in
accordance with previous reports [8,9,18,19]. In contrast, in slices
incubated with insulin, a clear shift of the holding current was
observed (Fig. 1Ab) revealing a tonic current induced by insulin. It
has been shown that 500 nM insulin increases miniature IPSCs
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16188(mIPSCs) amplitudes in pyramidal neurons [17] but effects on
tonic currents have not been reported. We examined a range of
insulin concentrations (0.5–100 nM) for their ability to induce
tonic currents in the CA1 pyramidal neurons. Only 0.5 nM insulin
failed to consistently induce tonic currents in neurons (50% of
trials, n=8). In slices incubated with 1nM insulin in the presence
of wortmannin (100 nM), an inhibitor of a key enzyme
phosphoinositide 3-kinases (PI3Ks) in the insulin receptors
intracellular cascade, no induced tonic current was detected
(n=8, data not shown). As insulin at concentrations greater than
1 nM can stimulate both the insulin receptors and insulin-like
growth factor-I receptors (IGF-IR) [20], we incubated the
hippocampal slices with 1 nM insulin in this study. One nM
insulin is also within the physiological range [4] and crosses the
blood-brain barrier by a saturable transport mechanism [21].
Tonic current levels recorded in the ACSF control and slices
treated with insulin for 1–3 h are shown in Fig. 1 Ac and d. In 22
of a total of 24 neurons tested did insulin induce tonic currents and
the averaged currents were similar at 1, 2 and 3 hrs (49.5627.1,
58.0616.4, 70.3621.9 pA) and significantly larger than in the
control slices (0.760.3 pA).
Insulin induced tonic current is carried by a5, c2
containing GABAA channels
In hippocampal CA1 pyramidal neurons either extrasynaptic a5
or d containing GABAA channels have been shown to carry the
small tonic current that may be present in the neurons at basal
ambient GABA concentrations [8,9,18,19,22] and increases when
the extracellular GABA concentration is elevated by external
applications of GABA [9,14,18]. We examined whether the insulin
Figure 1. Insulin (1 nM) induces tonic GABAA currents in CA1 pyramidal neurons. A. An ACSF (a) and an insulin-treated neuron (b, 2 h), SR-
95531 (20 mM). c, Amplitudes of tonic currents recorded in individual neurons; ACSF (n=11), incubated with insulin 1 h (n=6), 2 h (n=9), 3 h (n=9).
d, The averaged tonic current amplitudes, mean 6 SEM. * P,0.05, **P,0.01. B Inhibition of insulin induced tonic current by L655, 708 (5 mM) in the
absence (a) and presence (b) of TTX (1 mM) and a GABAB antagonist CGP 52432, SR-95531 (20 mM). c, % of total tonic current inhibited. ns, no
significance.
doi:10.1371/journal.pone.0016188.g001
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L655, 708 (5 mM) that is selective for channels containing the a5
and c2 subunits in the channel complex (Fig. 1B). In the insulin
treated slices, L655, 708 inhibited the holding current (8564%)
causing an upward shift of the current level and co-application of
SR-95531 further inhibited the current (1564%) (Fig. 1Ba, b, c).
This demonstrates that the insulin induced current is at least
partially carried by a5bc2 GABAA channels (Fig. 1Bc). We
repeated the experiments in the presence of the sodium channel
blocker TTX (tetrodotoxin, 1 mM) to inhibit action potential-
dependent synaptic activity and examined whether the large tonic
current observed after insulin incubation of the slices was related
to increased synaptic activity, resulting in higher extracellular
GABA concentrations from synaptic spillover of GABA and
thereby activating a larger proportion of the relatively low-affinity
(EC50.1 mM) GABAA channels that are present in the neurons
[23]. Interestingly, the average amplitude of the sIPSCs was
decreased from 37.861.4 pA to 21.460.4 pA (n=5) but the
induced tonic current remained (Fig. 1Bb, c) further suggesting
that the newly turned-on GABAA channels are more sensitive to
the ambient GABA, determined by e.g. GABA transporters
activity or synaptic spillover, than the ones normally expressed.
Insulin-induced GABAA tonic currents are inhibited by
flumazenil and zolpidem
GABAA channels are pentamers formed by subunits from 8
different families (a1–6, b1–4, c1–3, d, e, h, p, r1–3). The channel
is thought to be composed of two as, two bs and a third subunit
type that is often the d or the c2 subunit [24]. Whether the native
channels are homo or heteromeric in terms of the as and bs
subunits is not clear [25]. We examined two compounds that are
normally inert at a5bc2 channels: the benzodiazepine flumazenil
(1 mM) and zolpidem (100 and 200 nM), a positive modulator at
a1, a2 and a3i nabc2 channels. Surprisingly, in slices incubated
in insulin both flumazenil (Fig. 2A) and zolpidem (Fig. 2B) shifted
the holding current revealing the large insulin-induced tonic
current. Similar to L655, 708, flumazenil and zolpidem inhibited
the tonic current by 7666% and 8165%, respectively (Fig. 2).
Flumazenil and zolpidem had minimal effect on the holding
current level in the control slices (Flumaznil, n=8 and zolpidem,
n=6, Fig. 2A & B) consistent with other studies [14,26]. We
examined if L655, 708 and zolpidem affected the same population
of channels by first applying one and then the two drugs together
and examined the shift in the holding current (Fig. 2C). The results
show that it does not matter in which order the drugs are applied,
the effects are not additive. Rather, it appears that the first drug
applied occludes the effect of the other consistent with that the
drugs are acting on the same population of channels. At synapses,
flumazenil is normally inert whereas zolpidem is known to
potentiate the currents [14], characteristics that are maintained
in the insulin incubated slices (Fig. 3A & B).
Insulin-induced tonic conductance decreases the
excitability of CA1 pyramidal neurons
GABA-mediated tonic inhibitory conductances have been
shown to decrease excitability of neurons by modulating the firing
frequency of action potentials [15]. The CA1 pyramidal neurons
in slices incubated with insulin had on the average resting
membrane potential of 259.260.4 mV (n=10) whereas in
control slices it was 257.660.4 mV (n=6) and accordingly, we
found that insulin incubation of the slices significantly decreased
the action potential firing rate (23.261.2 Hz, n=10) as compared
Figure 2. Inhibition of insulin (1 nM) induced tonic current by flumazenil and zolpidem. Effects of flumazenil (A,1mM), zolpidem (B,
100 nM) and SR-95531 (20 mM) on the currents in an ACSF (a) and an insulin treated neuron (b). c, Amplitudes of tonic currents in individual neurons;
A: ACSF (n=8), insulin incubated (n=10); B: ACSF (n=6), insulin-incubated neurons (n=13). d, A & B, % of total tonic current inhibited by
antagonists. C. Tonic currents (a, b) in the presence of L655, 708 (5 mM) or zolpidem (100 nM) or the drugs together (L655, 708,5 mM; zolpidem,
100 nM) in insulin treated neurons. c. Amplitudes of the tonic currents in individual neurons (L655, 708 first applied alone: open circle, n=4; zolpidem
first applied alone: filled circle, n=4). d. Tonic current inhibited by L655, 708 plus zolpidem (n=8) normalized to the tonic current inhibited by either
L655, 708 or zolpidem in the same cell. ns, no significance.
doi:10.1371/journal.pone.0016188.g002
Figure 3. sIPSCs recordings in insulin-incubated neurons recorded before (2) and after (+) application of (A) flumazenil (1mM), (B)
zolpidem (200 nM) and total sIPSCs normalized to before flumazenil or zolpidem application, mean ± SEM, n=6. ** P,0.01.
doi:10.1371/journal.pone.0016188.g003
Insulin Turns-On Tonic GABAA Channels
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16188with ACSF control (27.761.6 Hz, n=6). Since flumazenil and
zolpidem inhibit the tonic current induced by insulin these drugs
can be expected to modulate the firing frequency of the CA1
neurons. Fig. 4A and B show that both 1 mM flumazenil and 100
or 200 nM zolpidem, respectively, significantly increase the action
potential firing rate in insulin-treated but not in ACSF control
neurons.
New, high-affinity GABAA channels are turned-on by
insulin
The average extracellular concentration of GABA has been
recorded to be about 25 nM in the dentate gyrus of the
hippocampus [10] where it activates high-affinity extrasynaptic
GABAA channels [27]. Under our experimental conditions, no
extracellular GABA was added and thus the tonic current must
have been activated by GABA concentrations existing within the
slice. We therefore examined in insulin-incubated slices if we could
activate GABAA channels using similar GABA concentrations
(10 nM) and then block these channels with flumazenil. The
results in Fig. 5 show channels that were first activated in intact
neurons in the cell-attached (ca) configuration. The patch was then
ripped off the cell and flumazenil was applied to the bath. We have
previously shown that benzodiazepines applied to the intracellular
phase of the cell membrane can cross the bilayer and modulate
channels from the extracellular side [26]. Fig. 5A shows 10 nM
GABA-activated 45 pS channel (2Vp=40 mV, Fig. 5A ai, bi, ci)
that was then inhibited by 1 mM flumazenil (Fig. 5A aiii, biii) and
remained closed until flumazenil was washed off (Fig. 5A aiv, biv,
civ). The channels showed outward rectification as shown by the
current-voltage relationship of a channel (m, filled triangles,
Fig. 5B) that was later blocked by 1 mM flumazenil. Similar IV
curves were recorded both in intact cells (#, open circles, n=18)
and ripped-off patches (h, open triangles, n=6). We then
examined what GABA concentrations could activate channels in
the intact CA1 pyramidal neurons and the results are shown in
Fig. 5C and D (2Vp=40 mV). Concentrations as low as 10 pM
could activate the channels and the average maximal-current
amplitude was reached with 1 nM GABA. The all-points
histograms in Fig. 5C are from 10 s current recordings and show
the gradual increase in single-channel current amplitude with
increased GABA concentration. All patches were later made
inside-out and the currents blocked with 1 mM flumazenil. In
Fig. 5D single-channel conductances from 52 cell-attached patches
at depolarized 40 mV (2Vp=40 mV) are plotted as open circles
and then those that were later blocked by 1 mM flumazenil as filled
circles. The data was fitted by a Hill-type equation (see methods)
Figure 4. Flumazenil and zolpidem increase the excitability of insulin-treated CA1 pyramidal neurons by inhibiting tonic GABAA
channels. Current-clamp traces illustrate action potential (AP) firing evoked by a 100 pA current step (500 ms) in ACSF (a) and insulin-incubated
neuron (b) before and after application of flumazenil (A,1mM) or zolpidem (B, 100 nM). Bar graphs; ACSF (FLU: n=4; ZOL: n=4), insulin incubated
neurons (FLU: n=6; ZOL: n=7). **, P,0.001.
doi:10.1371/journal.pone.0016188.g004
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(EC50)o f1 7 64 pM, Imax of 4861 pS and a Hill coefficient of
1.060.2. The ten pM GABA concentration activated channels
with the average maximum-conductance of 1862 pS (n=8) and a
noise baseline holding current (Fig. 5E). In the presence of 1 mM
flumazenil the channels were inhibited and the holding current
baseline noise decreased as can be seen by comparing the current
traces before and after the addition of flumazenil and evidenced by
the narrowing of the all-points histogram in the presence of the
flumazenil. The results are consistent with GABA activation of
channel subconductance states at even the low 10 pM GABA
concentration. These channels have by far the highest affinity for
GABA of any described GABAA channels and are activated by
about 10‘7 lower GABA concentrations than synaptic channels.
Discussion
Our results demonstrate that in hippocampal CA1 neurons,
physiological concentrations of insulin induce tonic conductance
that is generated by novel, high-affinity GABAA channels and
when in place, regulates the CA1 neurons excitability.
There appears to be numerous ways in which GABA mediated
tonic inhibition may arise; it can be activated by (1) the ambient
level of GABA around the neurons [9,10,23,27,28,29], (2) by
increased extracellular GABA concentrations by mechanisms such
as spillover of GABA from synapses or nonvesicular release of
GABA [18,23,28] or (3) as we have shown in this report, by insulin
which induces new high-affinity extrasynaptic receptors that can
sense the ambient level of GABA. If the ambient level of GABA in
the CA1 hippocampal region is similar to what it is in the dentate
gyrus (25 nM) then the new channels with an EC50 of 17 pM will
be saturated with GABA. In effect, insulin then acts as a switch to
turn-on tonic inhibition in the CA1 pyramidal neurons. As the
channels show outward rectification they are expected to
predominantly affect neurons at the spiking threshold [15] and
accordingly in our study the insulin-induced tonic conductance
decreased frequency of action potential firing in the CA1
pyramidal neurons.
Different GABAA channel assembles containing a1, a5, a4, a6,
c2, d or e subunits have been shown to mediate the tonic
conductance in CNS neurons [23,27,28,29,30]. In our study, the
insulin-induced tonic current is mainly carried by a5, c2
containing GABAA channels. GABAA channels having the a5
subunit in their channel complex are known to be mostly located
extrasynaptically in CA1 neurons but are not or minimally
activated by the ambient GABA concentration. How the new
channels differ from the a5-channels normally in the membrane is
not clear but heteromeric a subunits in the channel complex,
different intracellular modification or associations with intracellu-
lar proteins can all give rise to the differences observed [24,25].
Interestingly, the induced tonic current is inhibited by flumazenil
and zolpidem, indicating a distinct pharmacology of these novel
GABAA channels. In the presence of zolpidem there was a
significant increase in the action potential firing rate in insulin-
treated but not in ACSF control neurons. These results are
somewhat surprising as zolpidem potentiates the synaptic currents
and its effects on the tonic current would at least partially be
cancelled by the increased sIPSCs. Since the overall effect of
zolpidem in the insulin treated slices was increased excitability of
the neurons, it supports the notion [15,28,31] that tonic rather
than synaptic conductances regulate basal neuronal excitability
when significant tonic conductance is expressed.
Decline in cognitive abilities is associated with a number of
diseases including Alzheimer disease, dementia and diabetes
mellitus. These diseases already affect a large proportion of
populations worldwide and are increasing in prevalence. We have
identified a specific target in the hippocampus, a new subtype of
GABAA channels turned-on by insulin that may potentially prove
useful when rescuing cognition in these folk diseases.
Materials and Methods
Hippocampal slice preparation
Experiments were performed on hippocampal slices from
postnatal 16–22 days old Wistar rats. The animals were sacrificed
in accordance with local ethical guidelines and approved animal
care protocols by the Uppsala Djurfo ¨rso ¨ksetiska Na ¨mnd, Sweden
(Uppsalas’ animal ethics committee) and the study given the
approval ID C258/8. Hippocampal slices were prepared as
previously described [6]. In brief, the rat brain was quickly
removed and sagittal hippocampal slices (400 mm thick) were cut
with a vibratome (Leica VT1200) in an ice-cold artificial
cerebrospinal fluid (ACSF) containing (mM): 124 NaCl, 26
NaHCO3, 3 KCl, 1.3 MgSO4, 2.5 Na2HPO4, 2.5 CaCl2 and
10 glucose with pH 7.2–7.4 when bubbled with 95% O2 and 5%
CO2. Slices were incubated in the same ACSF solution at 37uC for
1h and then stored at room temperature (20–22uC). Insulin (0.5–
100 nM) was dissolved in ACSF and applied to the slices for 1–
3 hours.
Electrophysiological recording and analysis
All patch-clamp recordings were performed at room tempera-
ture (20–22uC). All drugs used were purchased from Sigma-
Aldrich or Ascent Scientific. SR-95531 was dissolved in the bath
solution. L655, 708, flumazenil and zolpidem were dissolved in
DMSO [26] to generate a stock solution that was later diluted in
the bath solutions to give the final concentration.
For the voltage-clamp recordings slices were perfused with
ACSF containing kynurenic acid (3 mM) and other drugs and
equilibrated with 95% O2 and 5% CO2. The pipette solution
containing (mM): 140 CsCl, 1CaCl2, 3 EGTA, 0.5 KCl, 1 MgCl2,
2 ATP-Mg, 0.3 GTP-Na, 5 QX-314 bromide, 10 TES, pH of 7.25
with CsOH. Recordings were made at 260 mV and rejected for
analysis if the access resistance changed more than 25%. For the
current-clamp recordings the slices were perfused with ACSF and
the pipette solution contained (in mM): 130 K-gluconate, 5 NaCl,
Figure 5. GABA activates single-channel currents in a graded manner and the currents are inhibited by flumazenil. A. 10 nM GABA-
activated channels in a cell-attached (ca) patch that was then ripped-off the cell and an inside-out (io) patch formed (2Vp=40 mV). a, In a reversible
manner 1 mM flumazenil inhibits the GABA-activated current. b, 30 s (i, ii, iv) and 3.5 min (iii) all-points open probability histograms c, Currents from
the trace shown in a (*) B. Average IV relation, currents activated by 10 nM GABA in ca (#, open circle, n=5–18), io (h, open triangle, n=3–6)
patches. m, filled triangle, an io patch were currents were later inhibited by 1 mM flumazenil. C. GABA-activated currents in ca patches (2Vp=40 mV)
and 10 s all-points open probability histograms. 0.01, 0.1, 1 and 1000 nM GABA activated 0.6, 1.3, 2.2 and 2.0 pA channels, respectively. All patches
were later made io and currents inhibited by 1 mM flumazenil. D. Conductance-GABA concentration relation, 52 ca patches, 2Vp=40 mV.N, patches
later made io and currents blocked with 1 mM flumazenil. E. 10 pM GABA-activated channels in a ca patch that was then ripped-off the cell and an io
patch formed (2Vp=40 mV). The recordings are from the io patch in 10 pM GABA in the absence and presence of 1 mM flumazenil and the all-points
histograms are each from a 10 s current trace that includes the sample trace shown.
doi:10.1371/journal.pone.0016188.g005
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pH 7.25 with NaOH. Single-channel recording solutions were:
chamber, mM: 140 NaCl, 5 KCl, 1 MgCl2, 1.8 CaCl2 and 10
TES, pH 7.25; pipette, mM: 140 Choline Cl, 5 NaCl, 1 KCl, 1
MgCl2, 1.8 CaCl2, 10 TES, pH 7.25, 200 mM saclofen and 0–
1 mM GABA. Electrodes were made from borosilicate glass and
the resistance was 2–4 MV (whole-cell recording) or 10–20 MV
(single-channel recording) when filled with the respective pipette
solution.
Patch-clamp recordings were done using an Axopatch 200B
amplifier, filtered at 2 kHz, digitized on-line at 10 kHz using an
analogue-to-digital converter and analyzed with pClamp (Molec-
ular Devices) and MiniAnalysis (Synaptosoft) programs. The
amplitude of the tonic current was measured as the difference in
the holding current level before and after drug application [8]. 50–
150 spontaneous inhibitory postsynaptic currents (sIPSCs) events
were randomly selected from each recording and total sIPSCs
calculated according to f6Q, f is the frequency of sIPSCs and Q is
the average value for charge transfer per sIPSC [8]. The
amplitude of single-channel currents was measured from peaks
in all-points histograms or by direct measurements of the single-
channel current amplitude. A Hill-type equation was fitted to the
single-channel data: c=cmax * [GABA]
n/[EC50]
n+[GABA]
n.
Statistical comparisons used unpaired student t-test or one-way
ANOVA.
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